OrganisationUS
BioPharma Dive
US digital news outlet covering pharmaceutical and biotech deal flow.
Last refreshed: 13 May 2026 · Appears in 1 active topic
Timeline for BioPharma Dive
#45 May
Mentioned in: CellCentric raises Europe's largest 2026 biotech round
UK Startups and InnovationCommon Questions
What is BioPharma Dive?
BioPharma Dive is a US digital trade publication owned by Industry Dive, covering pharmaceutical and biotech deal flow, regulatory decisions, and clinical trial results for industry professionals.Source: BioPharma Dive
Where can I read pharmaceutical industry deal news?
BioPharma Dive (biopharmadive.com) publishes daily newsletters covering pharma and biotech deals, regulatory approvals, and clinical results.Source: BioPharma Dive
Background
BioPharma Dive is cited as a source in reporting on CellCentric's £170m Series D in May 2026.
BioPharma Dive is a US-based digital trade publication covering pharmaceutical and biotechnology business news, focusing on deal flow, regulatory decisions, clinical trial results, and corporate strategy. It is owned by Industry Dive, a Washington DC-based specialist business media company. BioPharma Dive publishes daily newsletters widely read by biotech and pharma executives, investors, and analysts as a primary source for deal reporting in the life sciences sector.
